James Berry
Physician · Massachusetts General Hospital
Credentials: · · · ·
History
Research
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene
Neuron · 2018 · 571 citations
Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons
Cell Reports · 2014 · 517 citations
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis
New England Journal of Medicine · 2020 · 415 citations
72 papers
56 papers · 1 as a fellow
25 papers
25 papers
22 papers
22 papers
17 papers
16 papers
Grants
- 2023–2028
Access for All in ALS (ALL ALS) East Clinical Coordinating Center
National Institute of Neurological Disorders and Stroke · OT2
Contact PI · $71.5M · Massachusetts General Hospital
- 2026–2028
Clinical and Usability Validation of Gait Velocity (SV95C) Measured from Wearable Digital Sensors
Food and Drug Administration · U01
Contact PI · $878.2K · Massachusetts General Hospital
- 2023–2027
An Intermediate-Size Expanded Access Protocol for Amyotrophic Lateral Sclerosis with Pridopidine
National Institute of Neurological Disorders and Stroke · U01
PI · $29.6M · Massachusetts General Hospital
- 2023–2027
A Diagnostic Biomarker for Amyotrophic Lateral Sclerosis
Food and Drug Administration · U01
PI · $1.6M · Johns Hopkins University
Clinical trials
- 2019–2024
Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)
Principal investigator · Completed
Shionogi
- 2019–2022
Principal investigator · Active not recruiting · Phase 2
The Methodist Hospital Research Institute
- 2013–2015
Gilenya in Amyotrophic Lateral Sclerosis (ALS)
Principal investigator · Completed · Phase 2
Massachusetts General Hospital
- 2011–2016
A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers
Principal investigator · Completed
Massachusetts General Hospital